FULCRUM THERAPEUTICS INC (FULC)

US3596161097 - Common Stock

7.15  -0.26 (-3.51%)

After market: 7.15 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
2.81M6.34M19.16M8.82M0.00
Operating Expenses
113.47M118.47M100.22M80.43M84.22M
Research and Development
71.80M76.78M69.70M59.04M71.07M
Selling, General, and Administrative Expenses
41.67M41.69M30.52M21.39M13.15M
Operating Income
-110.66M-112.13M-81.05M-71.61M-84.22M
Interest Income/Expense
N/AN/AN/AN/A1.51M
Other Income/Expense
13.33M2.69M210.00K790.00K30.00K
Non Recurring Items
0.00-430.00KN/AN/AN/A
Income Before Taxes
-97.33M-109.87M-80.85M-70.82M-82.68M
Net Income
-97.33M-109.87M-80.85M-70.82M-89.81M
EBITDA
-108.49M-109.72M-78.53M-69.23M-82.17M
 
Per Share Data
EPS Diluted Total Ops
-1.59-2.44-2.29-2.79-3.96
Non GAAP EPS
-1.58-2.48-2.29-2.81N/A
 
Statistics
Profit Margin
-3470.05%-1732.97%-421.97%-802.95%N/A
Operating Profit Margin
-3945.24%-1768.61%-423.02%-811.90%N/A

All data in USD

Charts